Collection of Placenta for Mitochondria Isolation
Recruiting
- Conditions
- Pregnancy Related
- Registration Number
- NCT03762512
- Lead Sponsor
- Minovia Therapeutics Ltd.
- Brief Summary
Placenta will be collected and from these, mitochondrial will be harvested. Mitochondria will be used in mitochondrial augmentation therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
- Healthy females, singleton pregnancy
- Planned elective C-section
- uncomplicated pregnancy
Exclusion Criteria
- Donor positive for viruses tested
- Donor excessive smoker or drinker
- Donor known to carry mitochondrial disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Placenta donated immediate The purpose of this study is to collect placenta for the production of mitochondria. Therefore, only general measurements are taken such as placenta weight and health of mother during pregnancy. No further intervention or interaction with the mother will occur, and she does not receive any drug product or treatment prior to or after placenta donation.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sheba Medical Center Hospital- Tel Hashomer
🇮🇱Ramat Gan, Israel